High Cell Surface Death Receptor Expression Determines Type I Versus Type II Signaling*
Open Access
- 14 October 2011
- journal article
- Published by Elsevier BV
- Vol. 286 (41), 35823-35833
- https://doi.org/10.1074/jbc.m111.240432
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- Mutant K-Ras increases GSK-3β gene expression via an ETS-p300 transcriptional complex in pancreatic cancerOncogene, 2011
- Protein Kinase Cβ Modulates Ligand-induced Cell Surface Death Receptor AccumulationPublished by Elsevier BV ,2010
- XIAP discriminates between type I and type II FAS-induced apoptosisNature, 2009
- Context-dependent Bcl-2/Bak Interactions Regulate Lymphoid Cell ApoptosisJournal of Biological Chemistry, 2009
- The Many Roles of FAS Receptor Signaling in the Immune SystemImmunity, 2009
- The Fas–FADD death domain complex structure unravels signalling by receptor clusteringNature, 2008
- Directing cancer cells to self-destruct with pro-apoptotic receptor agonistsNature Reviews Drug Discovery, 2008
- The life of a cell: apoptosis regulation by the PI3K/PKB pathwayBiochemical Journal, 2008
- Quantitative Analysis of Pathways Controlling Extrinsic Apoptosis in Single CellsMolecular Cell, 2008
- Apoptosis by Death FactorCell, 1997